Photonpharma develops an autologous cell therapy platform for the treatment of solid tumor cancers.
Photonpharma has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Photonpharma is headquartered in Fort Collins, United States.
Photonpharma develops an autologous cell therapy platform for the treatment of solid tumor cancers.
Photonpharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Photonpharma — Funding & Investors." VCBacked, August 21, 2024, https://www.vcbacked.co/company/photonpharma. Accessed August 2, 2026.
VCBacked. (2024). Photonpharma — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/photonpharma
{{cite web |title=Photonpharma — Funding & Investors |url=https://www.vcbacked.co/company/photonpharma |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated